180 related articles for article (PubMed ID: 38099993)
21. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
Robella M; Vaira M; De Simone M
World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
[TBL] [Abstract][Full Text] [Related]
22. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
Luksta M; Bausys A; Bickaite K; Rackauskas R; Paskonis M; Luksaite-Lukste R; Ranceva A; Stulpinas R; Brasiuniene B; Baltruskeviciene E; Lachej N; Sabaliauskaite R; Bausys R; Tulyte S; Strupas K
BMC Cancer; 2023 Oct; 23(1):1032. PubMed ID: 37875869
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report.
Tempfer CB; Hartmann F; Hilal Z; Rezniczek GA
BMC Cancer; 2017 Jan; 17(1):26. PubMed ID: 28061769
[TBL] [Abstract][Full Text] [Related]
24. Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.
Graversen M; Detlefsen S; Bjerregaard JK; Fristrup CW; Pfeiffer P; Mortensen MB
Ther Adv Med Oncol; 2018; 10():1758835918777036. PubMed ID: 29899763
[TBL] [Abstract][Full Text] [Related]
25. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
[TBL] [Abstract][Full Text] [Related]
26. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in patients with ovarian cancer: A systematic review.
Taliento C; Restaino S; Scutiero G; Arcieri M; Bernardi G; Martinello R; Driul L; Perrone AM; Fagotti A; Scambia G; Greco P; Vizzielli G
Eur J Surg Oncol; 2023 Dec; 49(12):107250. PubMed ID: 37951158
[TBL] [Abstract][Full Text] [Related]
27. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries.
Račkauskas R; Baušys A; Lukšta M; Jurgaitis J; Paškonis M; Strupas K
World J Surg Oncol; 2021 Aug; 19(1):236. PubMed ID: 34376191
[TBL] [Abstract][Full Text] [Related]
28. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy.
Solass W; Kerb R; Mürdter T; Giger-Pabst U; Strumberg D; Tempfer C; Zieren J; Schwab M; Reymond MA
Ann Surg Oncol; 2014 Feb; 21(2):553-9. PubMed ID: 24006094
[TBL] [Abstract][Full Text] [Related]
29. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study.
Eveno C; Jouvin I; Pocard M
Pleura Peritoneum; 2018 Jun; 3(2):20180116. PubMed ID: 30911659
[TBL] [Abstract][Full Text] [Related]
30. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
[TBL] [Abstract][Full Text] [Related]
32. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
[TBL] [Abstract][Full Text] [Related]
33. First Clinical Data of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) as Salvage Therapy for Peritoneal Metastatic Biliary Tract Cancer.
Falkenstein TA; Götze TO; Ouaissi M; Tempfer CB; Giger-Pabst U; Demtröder C
Anticancer Res; 2018 Jan; 38(1):373-378. PubMed ID: 29277797
[TBL] [Abstract][Full Text] [Related]
34. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study.
Jansen-Winkeln B; Eberth J; Moulla Y; Mehdorn M; Niebisch S; Schierle K; Bläker H; Lordick F; Gockel I; Thieme R
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1331-1341. PubMed ID: 36513815
[TBL] [Abstract][Full Text] [Related]
35. Systematic review of patient reported outcomes (PROs) and quality of life measures after pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Taibi A; Geyl S; Salle H; Salle L; Mathonnet M; Usseglio J; Durand Fontanier S
Surg Oncol; 2020 Dec; 35():97-105. PubMed ID: 32862112
[TBL] [Abstract][Full Text] [Related]
36. Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis.
Tidadini F; Abba J; Quesada JL; Trilling B; Bonne A; Foote A; Faucheron JL; Arvieux C
J Gastrointest Cancer; 2023 Jun; 54(2):632-641. PubMed ID: 35778645
[TBL] [Abstract][Full Text] [Related]
37. Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence-The PIPAC-OPC4 Study.
Graversen M; Rouvelas I; Ainsworth AP; Bjarnesen AP; Detlefsen S; Ellebaek SB; Fristrup CW; Liljefors MG; Lundell L; Nilsson M; Pfeiffer P; Tarpgaard LS; Tsekrekos A; Mortensen MB
Ann Surg Oncol; 2023 Jul; 30(7):4433-4441. PubMed ID: 36867174
[TBL] [Abstract][Full Text] [Related]
38. Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2).
Khomyakov V; Ryabov A; Ivanov A; Bolotina L; Utkina A; Volchenko N; Kaprin A
Pleura Peritoneum; 2016 Sep; 1(3):159-166. PubMed ID: 30911619
[No Abstract] [Full Text] [Related]
39. Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
Raoof M; Whelan RL; Sullivan KM; Ruel C; Frankel PH; Cole SE; Tinsley R; Eng M; Fakih M; Chao J; Lim D; Woo Y; Paz IB; Lew M; Cristea M; Rodriguez-Rodriguez L; Fong Y; Thomas RM; Chang S; Deperalta D; Merchea A; Dellinger TH
Ann Surg Oncol; 2023 Nov; 30(12):7814-7824. PubMed ID: 37501051
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
